Pneumothorax triggered by the combination of gefitinib and amrubicin and treated with endobronchial silicone spigots

Pneumothorax triggered by the combination of gefitinib and amrubicin and treated with endobronchial silicone spigots

Pneumothorax is a rare complication in cancer chemotherapy. We report a case in which a male patient with advanced non-small cell lung cancer (NSCLC) developed repetitive pneumothorax after receiving a combination of the chemotherapeutic drugs gefitinib and amrubicin (GEF + AMR). Both episodes of pn...

Full description

Bibliographic Details
Main Authors: Fumio Imamura, Norio Okamoto, Takako Inoue, Junji Uchida, Kazumi Nishino, Madoka Kimura, Toru Kumagai, Jiro Okami
Format: Article
Language:English
Published: Elsevier 2015-01-01
Series:Respiratory Medicine Case Reports
Subjects:
Pneumothorax
Gefitinib
Amrubicin
Endoscopic bronchial occlusion
EWS
Online Access:http://www.sciencedirect.com/science/article/pii/S2213007115000118

Internet

http://www.sciencedirect.com/science/article/pii/S2213007115000118

Similar Items